Analysen zu Novo Nordisk
| 30.04.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
| 08.04.25 | Novo Nordisk Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | Novo Nordisk Buy | UBS AG | |
| 03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 31.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 24.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 21.03.25 | Novo Nordisk Buy | UBS AG | |
| 17.03.25 | Novo Nordisk Buy | UBS AG | |
| 14.03.25 | Novo Nordisk Buy | UBS AG | |
| 11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.03.25 | Novo Nordisk Buy | UBS AG | |
| 10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.03.25 | Novo Nordisk Buy | UBS AG | |
| 04.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.03.25 | Novo Nordisk Buy | UBS AG | |
| 26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.02.25 | Novo Nordisk Buy | UBS AG | |
| 19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.02.25 | Novo Nordisk Buy | UBS AG | |
| 17.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | UBS AG | |
| 10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Buy | UBS AG | |
| 05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | Novo Nordisk Buy | UBS AG | |
| 29.01.25 | Novo Nordisk Buy | UBS AG | |
| 29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 05.02.26 | BMW Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | London Stock Exchange Outperform | RBC Capital Markets | |
| 05.02.26 | OMV buy | UBS AG | |
| 05.02.26 | RATIONAL Overweight | Barclays Capital | |
| 05.02.26 | Hannover Rück Buy | Jefferies & Company Inc. | |
| 05.02.26 | Hannover Rück Kaufen | DZ BANK | |
| 05.02.26 | Evonik Equal Weight | Barclays Capital | |
| 05.02.26 | BNP Paribas Buy | UBS AG | |
| 05.02.26 | Vodafone Group Sell | UBS AG | |
| 05.02.26 | Santander Buy | UBS AG | |
| 05.02.26 | ArcelorMittal Neutral | UBS AG | |
| 05.02.26 | Hannover Rück Buy | UBS AG | |
| 05.02.26 | Shell Neutral | UBS AG | |
| 05.02.26 | Prosus Buy | UBS AG | |
| 05.02.26 | BBVA Buy | UBS AG | |
| 05.02.26 | RATIONAL Buy | UBS AG | |
| 05.02.26 | Siemens Healthineers Neutral | UBS AG | |
| 05.02.26 | Evonik Sell | Goldman Sachs Group Inc. | |
| 05.02.26 | BNP Paribas Outperform | RBC Capital Markets | |
| 05.02.26 | Hannover Rück Sector Perform | RBC Capital Markets | |
| 05.02.26 | Shell Sector Perform | RBC Capital Markets | |
| 05.02.26 | RATIONAL Underperform | RBC Capital Markets | |
| 05.02.26 | Vestas Wind Systems A-S Outperform | RBC Capital Markets | |
| 05.02.26 | Santander Halten | DZ BANK | |
| 05.02.26 | UBS Kaufen | DZ BANK | |
| 05.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.26 | Saint-Gobain Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | BNP Paribas Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | BBVA Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Vodafone Group Underweight | JP Morgan Chase & Co. | |
| 05.02.26 | Hannover Rück Neutral | JP Morgan Chase & Co. | |
| 05.02.26 | Vestas Wind Systems A-S Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Ferrari Overweight | Barclays Capital | |
| 05.02.26 | Beiersdorf Overweight | Barclays Capital | |
| 05.02.26 | Heidelberg Materials Overweight | Barclays Capital | |
| 05.02.26 | Bayer Overweight | Barclays Capital | |
| 05.02.26 | Siemens Healthineers Overweight | Barclays Capital | |
| 05.02.26 | Rheinmetall Overweight | Barclays Capital | |
| 05.02.26 | Hannover Rück Underweight | Barclays Capital | |
| 05.02.26 | Evonik Underperform | Jefferies & Company Inc. | |
| 05.02.26 | RATIONAL Outperform | Bernstein Research | |
| 05.02.26 | Linde Outperform | Bernstein Research | |
| 05.02.26 | Akzo Nobel Market-Perform | Bernstein Research | |
| 05.02.26 | BASF Outperform | Bernstein Research | |
| 05.02.26 | ArcelorMittal Hold | Jefferies & Company Inc. | |
| 05.02.26 | Siemens Healthineers Buy | Jefferies & Company Inc. | |
| 05.02.26 | Hannover Rück Buy | Jefferies & Company Inc. | |
| 05.02.26 | Vestas Wind Systems A-S Buy | Jefferies & Company Inc. | |
| 05.02.26 | Infineon Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.26 | Rheinmetall Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.